AG001WDG

165800-03-3 | Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-

AG001WDG

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	165800-03-3
Catalog Number	AG001WDG(AGN-PC-0Q8T98)
Chemical Name	Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
IUPAC Name	N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
InChI	InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
InChI Key	TYZROVQLWOKYKF-ZDUSSCGKSA-N
MDL Number	MFCD21604223
Molecular Formula	C16H20FN3O4
Molecular Weight	337.3461
SMILES	CC(NC[C@H]1CN(C2=CC=C(N3CCOCC3)C(F)=C2)C(O1)=O)=O
UNII	ISQ9I6J12J
Synonyms	100766, U, linezolid, linezolide, N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide, PNU 100766, PNU-100766, PNU100766, U 100766, U-100766, U100766, Zyvox, linezolid, 165800-03-3, Zyvox, Zyvoxid, (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, Zyvoxam, PNU-100766, PNU 100766, U-100766, U 100766, UNII-ISQ9I6J12J, C16H20FN3O4, HSDB 7478, CHEMBL126, ISQ9I6J12J, N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, CHEBI:63607, TYZROVQLWOKYKF-ZDUSSCGKSA-N, Linezolid, 98%, MFCD00937825, CPD000466335, (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide, Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide, N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide, N-{[(5s)-3-(3-Fluoro-4-Morpholin-4-Ylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]methyl}acetamide, Q-201308, LINEZOLIDE, Linezlid, Zivoxid, Zyvoxa, Linezolid [USAN:INN], Acetamide, N-(((5S)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, Acetamide, N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-, N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide, SMR000466335, ZLD, Zyvox (TN), SR-01000759376, Linezolid & VRC3375, Linezolidum, Linezoid, Linezolid (JAN/USAN/INN), Linezolid [USAN:INN:BAN], Linezolid(Zyvox), N-(((5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl)methyl)-acetamide, NCGC00164628-01, Linezolid (Zyvox), AK105905, N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide, 111GE017, NDA 21-130 Zyvox (linezolid tablets), N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide, AC1L9B3M, SCHEMBL5027, DSSTox_CID_26489, DSSTox_RID_81660, DSSTox_GSID_46489, MLS000759444, MLS001424075, BIDD:GT0404, Benzotriazol-2-yl-acetonitrile, cid_441401, Linezolid (PNU-100766), QCR-88, DTXSID5046489, Linezolid, >=98% (HPLC), NDA 21-131 Zyvox for injection (linezolid injection), SYN3021, (R)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, (S)-N-[[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide, HMS2051F08, HMS2089K06, HMS3260C14, HMS3713K10, NDA 21-132 Zyvox oral suspension (linzolid oral suspension), BCP05586, KS-00000BB5, ZINC2008866, Tox21_112246, Tox21_500096, BDBM50116067, GA2609, Linezolid|165800-03-3|Zyvoxid, s1408, AKOS016340522, AM84567, BCP9000855, CCG-101009, CS-0756, DB00601, KS-1178, NC00259, NCGC00260781-01, NCGC00263531-03, NCGC00263531-10, AJ-32488, AN-15409, CC-29960, CJ-07345, HY-10394, N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide, SAM001246624, SC-11638, AB0012049, AX8042607, LS-173594, ST2408359, TL8001272, CAS-165800-03-3, FT-0080803, FT-0602524, SW197639-3, C08146, D00947, J90009, M-8338, AB00639994-06, AB00639994-08, AB00639994-09, AB00639994_10, AB00639994_11, 800L033, A810662, C-20237, SR-01000759376-4, SR-01000759376-5, U-100,766, Linezolid, United States Pharmacopeia (USP) Reference Standard, (S)-N-((3-fluoro-4-morpholinophenyl)-2-oxaoxazolidin-5-yl)methyl)acetamide, Linezolid, Pharmaceutical Secondary Standard; Certified Reference Material, (Linezolid)N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide, (S)-N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide, (S)-N-[ [3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-oxazolidin-5-yl]methyl]-acetamide, (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide, N-[(R)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide, N-[(S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide, N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide, N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide(linezolid), (S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-5-[(1-hydroxy-ethylamino)-methyl]-oxazolidin-2-one, N-((S)-2-oxo-3-(S)-2,3,3a,4-tetrahydro-1H-benzo[b]pyrrolo[1,2-d][1,4]oxazin-7-yl-oxazolidin-5-ylmethyl)-acetamide, N-[[(5S)-3-(3-fluoranyl-4-morpholin-4-yl-phenyl)-2-oxidanylidene-1,3-oxazolidin-5-yl]methyl]ethanamide, linospan, linox, Zyvoxam (TN), Zyvoxid (TN), linezolid sodium chloride, D07UYO, cc-154, Linezolid, 98% - 10mg 10mg, C16-H20-F-N3-O4, CID441401, PNU100766, ACN-028794, CS-O-30960, A5181, A10533, C098010, U100766, 100766, U, D000069349, PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid,

Complexity	472
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	337.144g/mol
Formal Charge	0
Heavy Atom Count	24
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	337.351g/mol
Monoisotopic Mass	337.144g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	71.1A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0.7

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number